BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25007965)

  • 1. ERβ splice variant expression in four large cohorts of human breast cancer patient tumors.
    Wimberly H; Han G; Pinnaduwage D; Murphy LC; Yang XR; Andrulis IL; Sherman M; Figueroa J; Rimm DL
    Breast Cancer Res Treat; 2014 Aug; 146(3):657-67. PubMed ID: 25007965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer.
    Yan S; Dey P; Ziegler Y; Jiao X; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS
    Breast Cancer Res Treat; 2021 Jan; 185(2):281-292. PubMed ID: 33001337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer.
    Mandusić V; Nikolić-Vukosavljević D; Tanić N; Kanjer K; Neskovic-Konstantinović Z; Celeketić D; Dimitrijević B
    J Cancer Res Clin Oncol; 2007 Aug; 133(8):571-9. PubMed ID: 17457609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
    Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
    BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.
    Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D
    Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.
    Davies MP; O'Neill PA; Innes H; Sibson DR; Prime W; Holcombe C; Foster CS
    J Mol Endocrinol; 2004 Dec; 33(3):773-82. PubMed ID: 15591034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
    Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V
    Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M; Lynch IJ; Bhardwaj B
    Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer.
    Reese JM; Suman VJ; Subramaniam M; Wu X; Negron V; Gingery A; Pitel KS; Shah SS; Cunliffe HE; McCullough AE; Pockaj BA; Couch FJ; Olson JE; Reynolds C; Lingle WL; Spelsberg TC; Goetz MP; Ingle JN; Hawse JR
    BMC Cancer; 2014 Oct; 14():749. PubMed ID: 25288324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor β transcript variants associate with oncogene expression in endometrial cancer.
    Häring J; Skrzypczak M; Stegerer A; Lattrich C; Weber F; Görse R; Ortmann O; Treeck O
    Int J Mol Med; 2012 Jun; 29(6):1127-36. PubMed ID: 22378275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
    Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT
    BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression.
    Liu J; Sareddy GR; Zhou M; Viswanadhapalli S; Li X; Lai Z; Tekmal RR; Brenner A; Vadlamudi RK
    Cancer Res; 2018 Jun; 78(12):3176-3189. PubMed ID: 29661831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.
    Vinayagam R; Sibson DR; Holcombe C; Aachi V; Davies MP
    BMC Cancer; 2007 Jul; 7():131. PubMed ID: 17640362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
    Bozkurt KK; Kapucuoğlu N
    Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased estrogen receptor betacx expression during mammary carcinogenesis.
    Esslimani-Sahla M; Kramar A; Simony-Lafontaine J; Warner M; Gustafsson JA; Rochefort H
    Clin Cancer Res; 2005 May; 11(9):3170-4. PubMed ID: 15867209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers.
    Yan M; Rayoo M; Takano EA; ; Fox SB
    Breast Cancer Res Treat; 2011 Apr; 126(2):395-405. PubMed ID: 20490651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complete nuclear estrogen receptor family in the rainbow trout: discovery of the novel ERalpha2 and both ERbeta isoforms.
    Nagler JJ; Cavileer T; Sullivan J; Cyr DG; Rexroad C
    Gene; 2007 May; 392(1-2):164-73. PubMed ID: 17307310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention.
    Poola I; Fuqua SA; De Witty RL; Abraham J; Marshallack JJ; Liu A
    Clin Cancer Res; 2005 Oct; 11(20):7579-85. PubMed ID: 16243834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
    Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
    J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating oestrogen receptor mutations and splice variants in advanced prostate cancer.
    Qu LG; Wardan H; Davis ID; Iddawela M; Sluka P; Pezaro CJ
    BJU Int; 2019 Nov; 124 Suppl 1():50-56. PubMed ID: 31090242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.